Jonathan Fryer, MD

Jonathan Fryer, MD

Kim M. Olthoff, MD

Kim M. Olthoff, MD

Author: Sunil K. Geevarghese, MD, MSCI, FACS

1. Enhance recognition of aberrant hepatic arteries during procurement and understanding of various arterial reconstruction options

2. Review the pitfalls of procuring arterial and venous conduit

3. Describe the differences in the recipient hepatectomy for bicaval and piggyback orthotopic liver transplants

4. Understand indications for and steps of placing a patient on venovenous bypass

5. Manage intraoperative challenges with reperfusion including hemorrhage

6. Recognize the difficult hepatic artery anastomosis and means to handle it

7. Navigate donor-recipient bile duct size mismatch

Learning Objectives:

1. Describe the incidence, mechanisms and manifestations of Alcoholic Liver Disease
2. Describe the selection process for ESLD patients with ALD 
3. Describe the  stratagems of Transplant Centers in dealing with ALD patients
4. Describe the results of OLT in ALD patients

Author: Cary Caldwell, MD

1) To understand the differences between compensated and decompensated liver disease
2) To discuss the CPT versus MELD scoring systems as a classification of degree of liver disease
3) To describe the pathophysiology, diagnosis, and management of major complications of ESLD including ascites, spontaneous bacterial peritonitis,  hepatorenal syndrome, hepatic encephalopathy, and variceal hemorrhage. 

Author: Kawtar Al Khalloufi, MD

1. Define acute on top of chronic liver failure (ACLF)

2. Impact of ACLF/scoring systems (CLIF-SOFA scoring)
      Survival / mortality risk in ACLF
      Prevalence of ACLF among inhouse liver patients with cirrhosis
      Financial burden of ACLF
3. Pathophysiology and clinical presentation of ACLF
      Predisposing factors: (acute liver injury on top of chronic, extrahepatic process “bleed – infection”, un identified)
      Predisposition: (Genetic, Gut/ microbiotia, infection)
      Pathophysiology (SIRS, infection, MOF) 
4. Management?
      Medial management – role of liver support systems
      Prognostic criteria for survival
      To transplant or not ---Futile Transplant
      Role of LDLT

Author: Sameh Adel Fayek, MD, PhD

Gregory Gores, MD

Author: Babak J. Orandi, MD, PhD, MSc, FACS

Learning Objectives:

1. Define and diagnose MASH using current nomenclature 
2. Describe the epidemiologic burden and natural history of MASH
3. Select an evidence-based management strategy for MASH